.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Teva
Cantor Fitzgerald
Cerilliant
Julphar
Mallinckrodt
Dow
Chubb
Express Scripts
Novartis

Generated: June 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019965

« Back to Dashboard
NDA 019965 describes NOVOLIN L, which is a drug marketed by Novo Nordisk Inc and is included in two NDAs. Additional details are available on the NOVOLIN L profile page.

The generic ingredient in NOVOLIN L is insulin zinc susp semisynthetic purified human. There are thirty-eight drug master file entries for this compound. Additional details are available on the insulin zinc susp semisynthetic purified human profile page.

Summary for NDA: 019965

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength100 UNITS/ML
Approval Date:Jun 25, 1991TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Healthtrust
QuintilesIMS
Johnson and Johnson
Cantor Fitzgerald
Colorcon
Daiichi Sankyo
Baxter
Teva
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot